收藏切换
The effect of ivabradine in the treatment of acute myocardial infarction complicated with heart failure and its influence on cardiac function and inflammatory factors
收藏切换
Lijun ZHAO1, Rong XU2a, Li LI2b, Chang LIU1
World Clinical Drug | 2025, 46(11) : 1120 - 1126
Less
收藏切换
World Clinical Drug | 2025, 46(11): 1120-1126
• Article •
The effect of ivabradine in the treatment of acute myocardial infarction complicated with heart failure and its influence on cardiac function and inflammatory factors
Full
Lijun ZHAO1, Rong XU2a, Li LI2b, Chang LIU1
Affiliations
  • 1.Center for Drug Evaluation, Inspection and Monitoring of Ningxia Hui Autonomous Region, Yinchuan 750000,Ningxia Hui Autonomous Region, China
  • 2a.Department of Pharmacy, Ningxia Fourth People's Hospital, Yinchuan 750000, Ningxia Hui Autonomous Region, China
  • 2b.Department of General Internal Medicine, Ningxia Fourth People's Hospital, Yinchuan 750000, Ningxia Hui Autonomous Region, China
Published: 2025-11-10 doi: 10.13683/j.wph.2025.11.005
Outline
收藏切换
Objective

To explore the efficacy of ivabradine in patients with acute myocardial infarction (AMI)complicated with heart failure (HF) and its influence on cardiac function and inflammatory factors.

Methods

A total of 240 patients with AMI combined with HF who were admitted to our hospital from January 2022 to January 2024 were selected and randomly divided into the observation group and the control group, with 120 cases in each group. The control group was given conventional treatment, while the observation group was treated with ivabradine tablets in addition. Both groups were treated continuously for 10 weeks. The clinical efficacy, left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD), mean pulmonary artery pressure (MPAP), central venous pressure (CVP), pulmonary vascular resistance (PVR), soluble suppression of tumorigenicity 2 protein (sST2), troponin (cTn)Ⅰ, N-terminal pro-B-type natriuretic peptide (NT-proBNP), high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor (TNF)-α, interleukin (IL)-6 and adverse reactions were compared between the two groups.

Results

After treatment, the total effective rate of the observation group was 90.00%, significantly higher than 78.33% of the control group (P<0.05). The LVEF of the observation group was higher than that of the control group, while LVEDD and LVESD were lower than those of the control group. The differences were all statistically significant (P<0.05). The MPAP, CVP and PVR in the observation group were all lower than those in the control group, and the differences were statistically significant (P<0.05). The levels of serum sST2, cTnⅠ and NT-proBNP in the observation group were all lower than those in the control group, and the differences were statistically significant (P<0.05). The levels of serum hs-CRP, TNF-α and IL-6 in the observation group were all lower than those in the control group, and the differences were statistically significant (P<0.05). There was no statistically significant difference in the comparison of adverse reactions between the two groups (P>0.05).

Conclusion

Ivabradine is helpful to improve the therapeutic effect of AMI combined with HF, and has good safety. It is worthy of clinical promotion.

acute myocardial infarction  /  heart failure  /  ivabradine  /  cardiac function  /  inflammatory factor
赵丽君, 徐蓉, 李莉, 刘畅. 伊伐布雷定治疗急性心肌梗死合并心力衰竭效果及对心功能、炎症因子的影响. 世界临床药物, 2025 , 46 (11) : 1120 -1126 . DOI: 10.13683/j.wph.2025.11.005
Lijun ZHAO, Rong XU, Li LI, Chang LIU. The effect of ivabradine in the treatment of acute myocardial infarction complicated with heart failure and its influence on cardiac function and inflammatory factors[J]. World Clinical Drug, 2025 , 46 (11) : 1120 -1126 . DOI: 10.13683/j.wph.2025.11.005
Year 2025 volume 46 Issue 11
66
18
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.11.005
  • Receive Date:2025-04-28
  • Online Date:2026-11-09
  • Published:2025-11-10
Article Data
Affiliations
History
  • Received:2025-04-28
  • Revised:2025-09-12
Affiliations
    1.Center for Drug Evaluation, Inspection and Monitoring of Ningxia Hui Autonomous Region, Yinchuan 750000,Ningxia Hui Autonomous Region, China
    2a.Department of Pharmacy, Ningxia Fourth People's Hospital, Yinchuan 750000, Ningxia Hui Autonomous Region, China
    2b.Department of General Internal Medicine, Ningxia Fourth People's Hospital, Yinchuan 750000, Ningxia Hui Autonomous Region, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.11.005
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT